Viral vectors for gene delivery to the central nervous system. - Wikidata - wikimedia - TriplyDB

Viral vectors for gene delivery to the central nervous system.

Viral vectors for gene delivery to the central nervous system.

http://www.wikidata.org/entity/Q37946113

about

Biology of adeno-associated viral vectors in the central nervous system Specific transfection of inflamed brain by macrophages: a new therapeutic strategy for neurodegenerative diseases Microneedles As a Delivery System for Gene Therapy Generation of diverse neural cell types through direct conversion Obesity genetics in mouse and human: back and forth, and back again Gene delivery strategies to promote spinal cord repair Highly PEGylated DNA Nanoparticles Provide Uniform and Widespread Gene Transfer in the Brain Targeted delivery of self-complementary adeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guided focused ultrasound Evaluation of helper-dependent canine adenovirus vectors in a 3D human CNS model.A gammaherpesvirus establishes persistent infection in neuroblastoma cells Dab2 attenuates brain injury in APP/PS1 mice via targeting transforming growth factor-beta/SMAD signaling.Fiber-modified adenovirus for central nervous system Parkinson's disease gene therapy.Gene doping in sport - perspectives and risks Replication-competent infectious hepatitis B virus vectors carrying substantially sized transgenes by redesigned viral polymerase translation.Preferential lentiviral targeting of astrocytes in the central nervous system.Adeno-associated viral serotypes produce differing titers and differentially transduce neurons within the rat basal and lateral amygdala The production of viral vectors designed to express large and difficult to express transgenes within neurons.Current gene therapy using viral vectors for chronic pain Humans as Superorganisms: How Microbes, Viruses, Imprinted Genes, and Other Selfish Entities Shape Our Behavior.Methods for gene transfer to the central nervous system.Serotype-dependent transduction efficiencies of recombinant adeno-associated viral vectors in monkey neocortex Regression of schwannomas induced by adeno-associated virus-mediated delivery of caspase-1.Hydroxyl PAMAM dendrimer-based gene vectors for transgene delivery to human retinal pigment epithelial cells Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9.Targeting the full length of the motor end plate regions in the mouse forelimb increases the uptake of fluoro-gold into corresponding spinal cord motor neurons rAAV-compatible MiniPromoters for restricted expression in the brain and eye.Recent advances in RNA interference therapeutics for CNS diseases.Microglia-specific targeting by novel capsid-modified AAV6 vectors.Biodegradable DNA Nanoparticles that Provide Widespread Gene Delivery in the Brain Intraspinal AAV Injections Immediately Rostral to a Thoracic Spinal Cord Injury Site Efficiently Transduces Neurons in Spinal Cord and Brain.Gene Editing for Treatment of Neurological Infections.Recombinant adeno-associated virus vectors in the treatment of rare diseases.RNA interference in head and neck oncology.Engineering Botulinum Neurotoxin C1 as a Molecular Vehicle for Intra-Neuronal Drug Delivery.Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins The advent of AAV9 expands applications for brain and spinal cord gene delivery.Recent gene therapy advancements for neurological diseases.Gene therapy for Parkinson's disease: state-of-the-art treatments for neurodegenerative disease.Direct lineage conversion of astrocytes to induced neural stem cells or neurons.A novel region in the CaV2.1 α1 subunit C-terminus regulates fast synaptic vesicle fusion and vesicle docking at the mammalian presynaptic active zone.

P2860

Q21129328-4F92AED4-BEB4-408F-981E-7CA73052B100 Q21133553-FCEF4126-C370-43CF-AB2B-F58282F3AD4C Q26746026-657B6572-CE32-43CA-8D83-8DE87B9E43A1 Q26765258-B89A2554-7449-47B0-AF57-92D74379BFEF Q26782027-508CDCE1-C456-4D40-B1B8-3A9DDDE2FF85 Q26825131-D9718BAB-850B-4005-B991-187B3FF6F1EC Q28394137-97E86371-8D54-4B5D-AA4E-BB7D0FE0F0C1 Q30447740-2BC5DE8A-2F83-4811-A6F2-9FF5E5C2146E Q30843000-D1DDD161-9FBD-4B47-A0AD-30CC069E0851 Q34043000-0A91728B-799D-4E70-8C4C-A90A991312EA Q34096401-84C104EE-F4E0-4F53-8D38-8D7DB54F18E0 Q34102305-A87F83A1-E8A2-4B96-8442-C25B19D5C52E Q34374459-74BF63D1-8B0B-4727-98E4-3E15DEE57E5A Q34669990-3553DFC9-07E9-4E7B-92FD-163B8B28F065 Q35009241-5DD79D63-B79F-4F73-987B-0B0D0C669EF3 Q35095825-6CE655D3-BBE5-44DC-B231-9697067E2392 Q35177199-76104826-DC51-48FF-A803-A11CC750B88D Q35658521-2DB81DDC-54A9-4398-91E5-41B1EBB1A412 Q35692856-5B348E04-104D-4936-A69A-C433F0AD6030 Q35902332-794390E1-CC0A-461B-B4D6-C176390E7036 Q36508670-7D4372BD-E4FE-462D-A684-4C69294D1CAF Q36634951-8BF84FBB-0D66-41D0-8A75-4FB428FDD7A9 Q36702382-2BB62C7D-928E-4104-A095-7D1309B1FCA8 Q36757156-E67DF95A-41F8-47CB-8AC6-07D0EB7E472A Q36854770-6E66EBB8-C9C2-4EB9-8AAF-1553507D367D Q36887018-9E6DA6AA-D149-4DBA-8798-CF6FFA03F89C Q36983193-6E08495E-7E91-4598-BEA8-F3731F357503 Q37007749-2640BB96-B0E6-4360-BA62-FF5DC46D273E Q37019334-1E2E1730-AB9E-4D4E-BDE7-092C84495654 Q37065567-C5F56269-B507-4923-BFAF-D2CA51A06D4F Q37136471-D0D5BDA9-94C9-44E3-9153-3484D016701B Q37279525-ACCDF706-056D-4927-9FC8-0AB53E01DB92 Q37406819-A3F18937-3A16-46E8-A224-4BEA05A7C75B Q37654972-2BF189A1-1EF9-4AA9-8077-DFBFAAC8DEC1 Q37961564-2E6C122B-4014-4586-A57B-EA0C96642B39 Q38004089-1188DD9B-E255-45F3-A591-79E82FF5FA10 Q38085469-06CFFB8D-31C4-4C99-9389-16C5E097DAAC Q38112216-ECFCE360-12FC-4F9A-81C4-4023DC0C646D Q38411899-550E3248-6304-4AA8-93FF-BC909C898752 Q38429364-3BABD27B-3C4E-475A-80F6-3CFD56A636CE

P2860

Viral vectors for gene delivery to the central nervous system.

http://www.wikidata.org/entity/Q37946113

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Viral vectors for gene delivery to the central nervous system.

@en

Viral vectors for gene delivery to the central nervous system.

@nl

type

label

Viral vectors for gene delivery to the central nervous system.

@en

Viral vectors for gene delivery to the central nervous system.

@nl

prefLabel

Viral vectors for gene delivery to the central nervous system.

@en

Viral vectors for gene delivery to the central nervous system.

@nl

P1433

Q37946113-2E89E73F-19E5-4253-BB79-8036235B483B

P1476

Q37946113-E953FAB6-1D92-4539-93A4-705B99FC83A7

P2093

Q37946113-09581159-7352-4C99-A2D9-2EBEA4CDDDA7

Q37946113-B89DDF14-E240-4184-A466-B6202F298206

Q37946113-F2709F99-9B00-457F-9FCE-99A50A27CDAE

P2860

Q37946113-000A5B86-AC78-4188-ABBF-4DDDF85B2587

Q37946113-008CDC14-5A68-4186-B642-2E872BA66636

Q37946113-02BBA691-D2DF-4BC4-AA8E-7EEEDF064407

Q37946113-035A2393-C0BD-42E6-81D8-65F69ADF3EAF

Q37946113-04FF2E89-C337-4D32-A200-6EAEBB733041

Q37946113-0871A9D6-F408-43C2-B8BD-7A0DE1AEFF31

Q37946113-09D9B668-B6B6-46D9-81B6-219C928DB34B

Q37946113-0BCB0EF2-C341-4870-9758-F1F3F25E08EF

Q37946113-0C3D9146-AC90-4737-9541-B30254A40F94

Q37946113-0F6372EF-7EF1-4CAD-B4B8-6B43C4CE62A4

P304

Q37946113-68599521-2B9F-4CA8-8878-3E05E5001B3D

P31

Q37946113-40F8F9D7-794D-435B-BF5F-50A754750BAA

P356

Q37946113-28C66AB5-FA8F-4C29-8242-2AE3485D54A3

P433

Q37946113-B70623A7-15C3-4475-86B9-6DF97A60E699

P478

Q37946113-D0E8DFB5-9974-4D26-B6E1-75452858779A

P577

Q37946113-39BAFEAE-ED84-4E8F-BBD4-0DEE5B6F8D81

P5875

Q37946113-56A4859F-4E73-49EB-BBB4-B9A92F2FA403

P698

Q37946113-448FEDCA-0BFA-4445-BAF6-AE25C74E9CD1

P932

Q37946113-302538B5-469F-482D-8118-CC93F03E0669

P356

J.NBD.2011.09.014

P1433

Neurobiology of Disease

P1476

Viral vectors for gene delivery to the central nervous system.

@en

P2093

R Jude Samulski

http://www.w3.org/2001/XMLSchema#string

Steven J Gray

http://www.w3.org/2001/XMLSchema#string

Thomas B Lentz

http://www.w3.org/2001/XMLSchema#string

P2860

HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses

Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue.

Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

Lentiviral vectors in gene therapy: their current status and future potential

Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization

Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors

ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

P304

179-188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NBD.2011.09.014

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51723556

http://www.w3.org/2001/XMLSchema#string

P698

22001604

http://www.w3.org/2001/XMLSchema#string

P932

3293995

http://www.w3.org/2001/XMLSchema#string